STAMPEDE trial results and implications


Nick James (Professor of Oncology at the University of Warwick and Consultant at Queen Elizabeth Hospital, Birmingham) describes the STAMPEDE trial and discusses its implications for the treatment of metastatic prostate cancer.

Professor James was a speaker at the RSM winter meeting in Saalbach, Austria, 16-22 January 2016. Read more about the winter meeting here.

Web design and marketing agency Leamington Spa